CASP8 rs59308963: Understanding Prostate Cancer Risk Associations
The rs59308963 variant is a single nucleotide polymorphism located within the CASP8 gene. It has been identified in genetic research as a marker associated with prostate cancer risk assessment models.
What each genotype means
Baseline prostate cancer risk
This genotype is associated with the baseline risk profile for prostate cancer in the context of this specific genetic marker. Research indicates that this variant, located in an intronic region of the CASP8 gene, may influence gene expression and regulatory activity, though its specific contribution to individual cancer risk remains a subject of ongoing study. Please note that genetic risk is only one factor in health outcomes, and you should discuss any concerns about cancer screening with your healthcare provider.
This is a common genotype found across diverse global populations.
Baseline prostate cancer risk
This genotype is associated with the baseline risk profile for prostate cancer in the context of this specific genetic marker. Research indicates that this variant, located in an intronic region of the CASP8 gene, may influence gene expression and regulatory activity, though its specific contribution to individual cancer risk remains a subject of ongoing study. Please note that genetic risk is only one factor in health outcomes, and you should discuss any concerns about cancer screening with your healthcare provider.
This is a common genotype found across diverse global populations.
Baseline prostate cancer risk
This genotype is associated with the baseline risk profile for prostate cancer in the context of this specific genetic marker. Research indicates that this variant, located in an intronic region of the CASP8 gene, may influence gene expression and regulatory activity, though its specific contribution to individual cancer risk remains a subject of ongoing study. Please note that genetic risk is only one factor in health outcomes, and you should discuss any concerns about cancer screening with your healthcare provider.
This is a common genotype found across diverse global populations.
What is rs59308963?
The rs59308963 variant is a specific genetic change, or single nucleotide polymorphism (SNP), located in the intronic region of the CASP8 gene. Introns are non-coding sections of DNA that sit between the coding sequences of a gene. While they do not provide the direct instructions for building proteins, they often play critical roles in regulating how genes are turned on or off. Researchers study these variants to understand how subtle differences in our DNA sequence might influence biological processes. In the case of rs59308963, its location within the CASP8 region has made it a subject of interest for scientists investigating the genetic architecture of various health conditions, particularly those related to cell regulation and cancer susceptibility.
The Role of the CASP8 Gene
The CASP8 gene provides instructions for making an enzyme called caspase-8. This protein is a key player in the extrinsic pathway of apoptosis, which is the body's programmed process for cell death. Apoptosis is essential for maintaining health because it allows the body to eliminate damaged, unnecessary, or potentially harmful cells. When the apoptosis pathway is disrupted, cells that should have been cleared away may continue to grow and divide uncontrollably, which is a hallmark of cancer development. Because caspase-8 acts as an initiator in this process, variations in the CASP8 gene are frequently studied to see if they alter the efficiency of this cell-death mechanism, potentially influencing an individual's susceptibility to certain types of tumors.
Research and Evidence Strength
Current research into rs59308963 indicates a moderate level of evidence linking it to prostate cancer risk assessment. Studies have observed that this variant is part of a region on chromosome 2q33.1 that harbors multiple signals related to cancer susceptibility. Some research suggests that this specific SNP is highly correlated with other variants in the region that may influence regulatory elements. While statistical associations have been reported in large-scale studies, it is important to note that genetic associations are complex. Many factors, including environmental influences and other genetic markers, contribute to cancer risk. The evidence for rs59308963 is primarily based on statistical correlations observed in population-level data rather than a direct, singular cause-and-effect relationship.
Population Frequency
The rs59308963 variant is considered a common genetic marker. In genomics, a variant is typically classified as common if it appears frequently across different ancestral groups. Because it is common, many individuals carry one or both copies of the variant allele. However, the exact frequency can vary depending on the specific population being studied. Geneticists use this information to help refine risk models, as understanding the baseline frequency of a variant helps determine whether a specific genotype is significantly more or less common in individuals with a particular health condition compared to the general population.
What This Information Means for You
It is important to understand that having a specific genotype for rs59308963 does not mean an individual will develop prostate cancer, nor does it guarantee protection. Genetic risk markers are tools used by researchers to understand population-level trends and biological pathways. They are not diagnostic tests. If you are concerned about your personal health or family history, the most appropriate step is to consult with a healthcare professional or a genetic counselor. They can provide context based on your full medical history, lifestyle factors, and other clinical indicators. Never use information about a single SNP to make medical decisions or change your health habits without professional guidance.
How common is this variant?
The rs59308963 variant is classified as a common variant, meaning it is found at significant frequencies across diverse human populations.
Frequently asked questions
Is rs59308963 a diagnostic test for prostate cancer?
No, rs59308963 is not a diagnostic test. It is a genetic marker used in research to study statistical associations with cancer risk, and it cannot determine if you have or will develop prostate cancer.
Should I be worried if I have the minor allele for this SNP?
Genetic associations are complex and involve many factors. Having a specific allele does not mean you are destined to develop a disease, and you should discuss any health concerns with your doctor.
How does CASP8 affect cancer risk?
CASP8 is involved in apoptosis, the process of programmed cell death. Variations in this gene may influence how effectively the body removes damaged cells, which is a factor researchers study in relation to cancer susceptibility.
Where can I find more information about my genetic risk?
If you are interested in your personal genetic risk, you should consult a board-certified genetic counselor or your primary care physician. They can interpret genetic information in the context of your overall health.
Sources & further reading
Educational information only, last refreshed 10/28/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs59308963?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29